ANTIBACTERIAL AND SYNERGISTIC ACTIVITY OF TERMINALIA CHEBULA AND TERMINALIA BELLERICA FRUIT EXTRACTS AGAINST ESBL PRODUCERS
Objective: Bacterial infections and the resistance related to indiscriminate antibiotic use have led to an alarming situation in the clinics. The rapid spread of Extended Spectrum Beta Lactamases (ESBLs) and carbapenemase producing Gram negative bacteria has initiated the need for development of a new drug or an alternative choice by using the combination of drugs with medicinal plant extracts. This study was aimed at examining the antibacterial potential and synergistic activity of ethanolic extracts of Terminalia chebula and Terminalia bellerica fruits against clinically important reference bacterial strains.
Methods: The crude ethanolic extracts of T. chebula and T. bellerica fruits were prepared and reconstituted with 5% dimethylsulfoxide (DMSO). The fruit extracts (~25 mg/well) were added into the wells in the plates inoculated with various ESBL and AmpC producers and they were incubated at 37 Â°C for 24 h. The antibiotics ceftazidime (30 Âµg) and cefotaxime (30 Âµg) were added to the wells alone and in combination with the fruit extracts to determine their own antibacterial and synergistic activity respectively.
Results: The ethanolic fruit extracts combination improved the activity of ceftazidime and cefotaxime against the tested ESBL and AmpC producers. Though both the extracts showed activity, T. chebula was found to show better synergistic antibacterial activity.Conclusion: The synergistic activity of these fruit extracts with ceftazidime and cefotaxime against the ESBL and AmpC producers shows the efficiency of the combination therapy, which can be considered in therapeutic point of view to prevent the misuse of antibiotics and minimise the increasing resistance in bacteria.
2. The wealth of India-A dictionary of Indian raw materials and industrial products. Vol. X. New Delhi: Publication and Information Directorate, CSIR; 2002. p. 522-4.
3. The wealth of India-A dictionary of Indian raw materials and industrial products. Vol. X. New Delhi: Publications and Information Directorate, CSIR; 2002. p. 387.
4. Chanda S, Rakholiya K. Combination therapy: Synergism between natural plant extracts and antibiotics against infectious diseases. In: Mendez-Vilas A. Ed. Science against Microbial Pathogens: Communicating Current Research and Technological Advances. Formatex Research Center; 2011. p. 520-9.
5. Pankey G, Ashcraft D, Patel N. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob Agents Chemother 2005;49:5166-8.
6. Kannan P, Ramadevi SR, Waheeta Hopper. Antibacterial activity of Terminalia chebula fruit extract. Afr J Microbiol Res 2009;3:180-4.
7. Anwesa Bag, Subir Kumar Bhattacharyya, Rabi Ranjan Chattopadhyay. The development of Terminalia chebula Retz. (Combretaceae) in clinical research. Asian Pac J Trop Biomed 2013;3:244-52.
8. Bag A, Bhattacharyya SK, Bharati P, Pal NK, Chattopadhyay RR. Evaluation of antibacterial properties of Chebulic myrobalan (fruit of Terminalia chebula Retz.) extracts against methicillin resistant Staphylococcus aureus and trimethoprim-sulphamethoxazole resistant uropathogenic Escherichia coli. Afr J Plant Sci 2009;3:25-9.
9. Nisrat Jahan, Sharifa Jahan. Study on synergistic activity of ethanolic leave extract of Terminalia chebula in combination to Azithromycin and Ciprofloxacin against various bacterial strains. Eur J Med Plants 2016;13:1-11.
10. Elizabeth KM. Antimicrobial activity of Terminalia bellerica. Indian J Clin Biochem 2005;20:150-3.
11. Rastogi P, Mehrotra BN. Compendium of Indian medicinal plants, drug research perspective, CDRI, Lucknow and NISCOM, New Delhi 1999;2:1-859.
12. Mounyr Balouiri, Moulay Sadiki, Saad Koraichi Ibnsouda. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal 2016;6:71â€“9.
13. Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. J Ethnopharmacol 1998;62:183-93.
14. Phadke SA, Kulkarni SD. Screening of in vitro antibacterial activity of Terminalia chebula, Eclapta alba and Ocimum sanctum. Indian J Med Sci 1989;43:113-7.
15. Ghosh A, Das BK, Roy A, Mandal B, Chanda G. Antibacterial activity of some medicinal plant extracts. J Nat Med 2008;62:259-62.
16. Sato Y, Oketani H, Singyouchi K, Ohtsubo T, Kihara M, Shibata H, et al. Extraction and purification of effective antimicrobial constituents of Terminalia chebula Retz. against methicillin-resistant Staphylococcus aureus. Biol Pharm Bull 1997;4:401-4.
17. Chattopadhyay RR, Bhattacharyya SK, Medda C, Chanda S, Datta S, Pal NK. Antibacterial activity of black myrobalan (Fruit of Terminalia chebula Retz.) against uropathogen Escherichia coli. Pharmacogn Rev 2007;11:212-5.
18. Suguna L, Singh S, Sivakumar P, Sampath P, Chandrakasan G. Influence of Terminalia chebula on dermal wound healing in rats. Phytother Res 2002;16:227-31.
19. Nithya Devi P, Kaleeswari S, Poonkothai M. Antimicrobial activity and Phytochemical analysis of fruit extracts of Terminalia bellerica. Int J Pharm Pharm Sci 2014;6:639-42.
20. Anindita Deb, Sikha Barua, Biswajit Das. Pharmacological activities of Baheda (Terminalia bellerica): a review. J Pharmacogn Phytochem 2016;5:194-7.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.